Duxin Sun
Impact in
- Pharmaceutical Science top 0.2%
- Oncology top 0.5%
Papers in
- Oncology 78
- Peptidase Inhibition and Analysis 20
- Cancer Cells and Metastasis 18
- Drug Transport and Resistance Mechanisms 17
- Co-authors
- Simon ZhouWei GaoHongxiang HuHongwei ChenHebao YuanKanokwan SansanaphongprichaXin LuanShaomeng Wang
- Journals
- Journal of Medicinal Chemistry (47 papers)Molecular Pharmaceutics (14 papers)Cancer Research (13 papers)The AAPS Journal (12 papers)Journal of Biological Chemistry (8 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Duxin Sun
275 papers receiving 14.6k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Pharmaceutical Science 887
- Oncology 3.3k
- Molecular Biology 8.3k
- Cancer Research 1.7k
- Toxicology 315
Countries citing papers authored by Duxin Sun
This map shows the geographic impact of Duxin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duxin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duxin Sun more than expected).
Fields of papers citing papers by Duxin Sun
This network shows the impact of papers produced by Duxin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duxin Sun. The network helps show where Duxin Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Duxin Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 40 | |
| 7 | 2022 | 17 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 104 | |
| 10 | 2021 | 110 | |
| 11 | 2020 | 13 | |
| 12 | 2018 | 124 | |
| 13 | 2018 | 10 | |
| 14 | 2017 | 45 | |
| 15 | 2017 | 15 | |
| 16 | 2013 | 158 | |
| 17 | 2012 | 12 | |
| 18 | 2010 | 443 | |
| 19 | 2008 | 306 | |
| 20 | 2007 | 67 |
About Duxin Sun
Duxin Sun is a scholar working on Pharmaceutical Science, Oncology, Pharmacology, Toxicology and Molecular Biology, having authored 281 papers that have together received 14.9k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (29 papers), Nanoparticle-Based Drug Delivery (27 papers), Ubiquitin and proteasome pathways (24 papers), Nanoplatforms for cancer theranostics (22 papers), Peptidase Inhibition and Analysis (20 papers), Cancer Cells and Metastasis (18 papers), Drug Transport and Resistance Mechanisms (17 papers) and Heat shock proteins research (16 papers). The work is most often cited by research in Pharmaceutical Science (887 citations), Oncology (3.3k citations), Molecular Biology (8.3k citations), Cancer Research (1.7k citations) and Toxicology (315 citations). Duxin Sun has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Simon Zhou, Wei Gao, Hongxiang Hu, Hongwei Chen, Hebao Yuan, Kanokwan Sansanaphongpricha, Xin Luan, Shaomeng Wang, Bo Wen and Peng Zou. Their work appears in journals such as Journal of Medicinal Chemistry, Molecular Pharmaceutics, Cancer Research, The AAPS Journal and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.